Christopher Bogart - InMed Pharmaceuticals Insider

InMed Pharmaceuticals Inc -- USA Stock  

USD 0.77  0.012  1.54%

Co-Founder and Sr. VP of Corporate Strategy and Investor Relations

We currently do not have informatin regarding Christopher Bogart. This executive tanure with InMed Pharmaceuticals Inc is not currenlty determined.
Age: 44        
604-683-2509  http://www.inmedpharma.com

Management Efficiency

The company has return on total asset (ROA) of (79.32) % which means that it has lost $79.32 on every $100 spent on asset. This is way below average. Similarly, it shows return on equity (ROE) of (135.95) % meaning that it generated substantial loss on money invested by shareholders.

Entity Summary

InMed Pharmaceuticals Inc., a preclinical stage biopharmaceutical company, engages in the research and development of novel and cannabinoidbased therapies in Canada. InMed Pharmaceuticals Inc (IMLFF) is traded on OTC Market in USA. It is located in Vancouver, BC VC T and employs 6 people.

Did you try this?

Run Commodity Channel Index Now
   

Commodity Channel Index

Use Commodity Channel Index to analyze current equity momentum
Hide  View All  NextLaunch Commodity Channel Index
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add InMed Pharmaceuticals Inc to your portfolio

Top Management

InMed Pharmaceuticals Inc Leadership Team

Stock Performance

InMed Pharmaceuticals Performance Indicators